MedPath

江苏亚邦强生药业有限公司

Ownership
-
Established
2006-04-06
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

42

NMPA:42

Drug Approvals

Metronidazole，Clotrimazole and Chlorhexidine Acetate Cream

Product Name
双唑泰乳膏
Approval Number
国药准字H20090204
Approval Date
Sep 1, 2023
NMPA

Ecabet Sodium Granules

Product Name
依卡倍特钠颗粒
Approval Number
国药准字H20183075
Approval Date
Nov 21, 2022
NMPA

Cefdinir Dispersible Tablets

Product Name
头孢地尼分散片
Approval Number
国药准字H20130013
Approval Date
Jul 19, 2022
NMPA

Cefdinir Dispersible Tablets

Product Name
头孢地尼分散片
Approval Number
国药准字H20173206
Approval Date
Jul 19, 2022
NMPA

Indapamide Tablets

Product Name
吲达帕胺片
Approval Number
国药准字H20123307
Approval Date
Apr 22, 2022
NMPA

Nateglinide Tablets

Product Name
那格列奈片
Approval Number
国药准字H20070180
Approval Date
Feb 11, 2022
NMPA

Finasteride Capsules

Product Name
非那雄胺胶囊
Approval Number
国药准字H20070077
Approval Date
Aug 5, 2021
NMPA

Beclometasone Dipropionate Cream

Product Name
丙酸倍氯米松乳膏
Approval Number
国药准字H32021432
Approval Date
Jun 22, 2020
NMPA

Lithium Carbonate Tablets

Product Name
碳酸锂片
Approval Number
国药准字H32023287
Approval Date
Jun 22, 2020
NMPA

Nadifloxacin Cream

Product Name
依尤宁
Approval Number
国药准字H20052475
Approval Date
Jun 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.